Dipeptide diaminobutyroyl benzylamide (diacetate)

Dipeptide diaminobutyroyl benzylamide diacetate, a Wagerlin-1-mimicking peptide, is a mAChR antagonist. Dipeptide diaminobutyroyl benzylamide diacetate can induce muscle relaxation. Dipeptide diaminobutyroyl benzylamide diacetate can be used in the research of skin aging, especially facial wrinkles (such as crow's feet and wrinkles around the eyes) [1][2].

Product Specifications

CAS Number

[823202-99-9]

UNSPSC

12352209

Hazard Statement

H302, H315, H319, H335

Target

MAChR

Type

Peptides

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Endocrinology

Assay Protocol

https://www.medchemexpress.com/dipeptide-diaminobutyroyl-benzylamide-diacetate.html

Purity

99.72

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

CC(O)=O.O=C(NCC1=CC=CC=C1)[C@H](CCN)NC([C@H]2N(CCC2)C(CCN)=O)=O.CC(O)=O

Molecular Formula

C23H37N5O7

Molecular Weight

495.57

Precautions

H302, H315, H319, H335

References & Citations

[1]Nathan S Trookman, et al. Immediate and Long-term Clinical Benefits of a Topical Treatment for Facial Lines and Wrinkles. J Clin Aesthet Dermatol. 2009 Mar;2 (3) :38-43.|[2]D'Arcangelis A, et al. In vitro, ex vivo, instrumental and clinical evaluation of a topical cream on the signs of periorbital ageing. Int J Cosmet Sci. 2025 Feb;47 (1) :18-30.